The Women’s Health Initiative (WHI) Clinical Trials
Long-Term Follow-up Findings (2020): View the study on PubMed
This landmark publication evaluates the 20-year outcomes regarding breast cancer incidence and mortality between combined and estrogen-only therapies. (Chlebowski et al., 2020)
2. The Collaborative Group on Hormonal Factors in Breast Cancer
Global Epidemiological Meta-Analysis (2019): View the analysis overview on the Oxford Cancer Epidemiology Unit
This massive global collaboration reanalyzed data from over 100,000 women across dozens of epidemiological studies to define how different types and durations of HRT affect long-term breast cancer risks.
3. The Million Women Study
Study Design and Cohort Characteristics: View the study via NCBI PMC
This provides the foundational data and operational structure for the UK population-based cohort tracking real-world health outcomes in relation to HRT use.
4. Comprehensive Literature & Oncology Reviews
Oncological Benefit-Risk Profile Review: View the full text via NCBI PMC
A broad review analyzing the balance of risks regarding endometrial, ovarian, breast, and colorectal cancers.
Modern Formulations & Breast Cancer Risk Analysis: View the full text via NCBI PMC
A review investigating how different synthetic versus alternate biological hormone paths interact with breast tissue.
Tabooki2@lemmy.world 3 days ago
The Women’s Health Initiative (WHI) Clinical Trials Long-Term Follow-up Findings (2020): View the study on PubMed This landmark publication evaluates the 20-year outcomes regarding breast cancer incidence and mortality between combined and estrogen-only therapies. (Chlebowski et al., 2020) 2. The Collaborative Group on Hormonal Factors in Breast Cancer Global Epidemiological Meta-Analysis (2019): View the analysis overview on the Oxford Cancer Epidemiology Unit This massive global collaboration reanalyzed data from over 100,000 women across dozens of epidemiological studies to define how different types and durations of HRT affect long-term breast cancer risks. 3. The Million Women Study Study Design and Cohort Characteristics: View the study via NCBI PMC This provides the foundational data and operational structure for the UK population-based cohort tracking real-world health outcomes in relation to HRT use. 4. Comprehensive Literature & Oncology Reviews Oncological Benefit-Risk Profile Review: View the full text via NCBI PMC A broad review analyzing the balance of risks regarding endometrial, ovarian, breast, and colorectal cancers. Modern Formulations & Breast Cancer Risk Analysis: View the full text via NCBI PMC A review investigating how different synthetic versus alternate biological hormone paths interact with breast tissue.
Anarki_@lemmy.blahaj.zone 3 days ago
Bro came back with sources on a shitpost
QuinnyCoded@sh.itjust.works 3 days ago
having boobs makes you at a higher risk to get breast cancer? color me surprised
thethunderwolf@lemmy.dbzer0.com 3 days ago
hmm yes transfems can totally get ovarian cancer
the post is talking about gender affirming hrt not menopause hrr